You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Phase 1 Bioequivalence Study

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Bioequivalence Trial in Tempe, Lincoln (efgartigimod PH20 SC as a prefilled syringe presentation, efgartigimod PH20 SC as a vial

Recruiting
  • Bioequivalence
  • efgartigimod PH20 SC as a prefilled syringe presentation
  • efgartigimod PH20 SC as a vial + syringe presentation
  • Tempe, Arizona
  • +1 more
Apr 5, 2023

Healthy Adult Subjects Trial in San Antonio (TTYP01, Radicava, Radicava ORS)

Recruiting
  • Healthy Adult Subjects
  • San Antonio, Texas
    ICON Early Phase Services
Oct 24, 2023

Healthy Volunteers (Intended Indication: Type 2 Diabetes) Trial in Berlin (Dapagliflozin/sitagliptin FDC, Sitagliptin,

Completed
  • Healthy Volunteers (Intended Indication: Type 2 Diabetes Mellitus)
  • Dapagliflozin/sitagliptin FDC
  • +2 more
  • Berlin, Germany
    Research Site
Jun 30, 2022

Leukemia, MDS, Acute Myeloid Leukemia Trial in Houston (Cladribine)

Not yet recruiting
  • Leukemia
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 28, 2023

Healthy Trial (Daridorexant 10 mg, Daridorexant 25 mg)

Not yet recruiting
  • Healthy
  • Daridorexant 10 mg
  • Daridorexant 25 mg
  • (no location specified)
Jun 1, 2023

Type 2 Diabetes Trial in Daejeon (CT-L01, Alogliptin Benzoate 25 mg, Metformin HCl XR 1,000 mg)

Completed
  • Healthy
  • Daejeon, Korea, Republic of
    Chungnam National University Hospital
Jan 10, 2023

Safety, Tolerability, Pharmacokinetics Trial in Karachi (RHN-001 (one tablet 750mg), RHN-001 (750mg * 2 Tablets))

Completed
  • Safety
  • +2 more
  • RHN-001 (one tablet 750mg)
  • RHN-001 (750mg * 2 Tablets)
  • Karachi, Sindh, Pakistan
    Center for Bioequivalence Studies and clinical research (CBSCR),
Apr 26, 2023

Essential Hypertension Trial in Seoul (L04RD1, L04TD3)

Completed
  • Essential Hypertension
  • Seoul, Korea, Republic of
    H plus Yangji Hospital
Aug 7, 2023

Smallpox Trial in Overland Park (Brincidofovir)

Recruiting
  • Smallpox
  • Overland Park, Kansas
    Altasciences
Jul 5, 2023

Healthy Volunteers Trial in Berlin (Zoliflodacin Patheon)

Recruiting
  • Healthy Volunteers
  • Zoliflodacin Patheon
  • Berlin, Germany
    Parexel Early Phase Clinical Unit
Nov 22, 2022

Parkinson Disease Trial in Orlando (Tavapadon)

Recruiting
  • Parkinson Disease
  • Orlando, Florida
    Orlando, Florida
Jan 17, 2023

Healthy Trial in Seoul (L04RD1, L04TD1)

Completed
  • Healthy
  • Seoul, Korea, Republic of
    H plus Yangji Hospital
Jan 10, 2023

Achondroplasia Trial in Dallas (BMN 111 administration via Injector Pen, BMN 111 administration via vial and syringe)

Recruiting
  • Achondroplasia
  • BMN 111 administration via Injector Pen
  • BMN 111 administration via vial and syringe
  • Dallas, Texas
    Labcorp
Apr 2, 2023

Healthy Trial in Seoul (L04RD1, L04TD2)

Completed
  • Healthy
  • Seoul, Korea, Republic of
    Jaewoo Kim
Jan 10, 2023

Healthy Adult Participants Trial in Baltimore (Treatment A, Treatment B, Treatment C)

Completed
  • Healthy Adult Participants
  • Treatment A
  • +2 more
  • Baltimore, Maryland
    Baltimore Parexel EPCU
Jan 19, 2023

Healthy Trial in Tempe (Lazertinib)

Recruiting
  • Healthy
  • Tempe, Arizona
    Celerion
Feb 23, 2023

Overweight or Obesity Trial in Uppsala (Xenical® vs EMP 22, EMP 22 vs Xenical®, EMP 16 vs Xenical®)

Not yet recruiting
  • Overweight or Obesity
  • Xenical® vs EMP 22
  • +2 more
  • Uppsala, Sweden
    CTC Clinical Trial Consultanta AB
Aug 25, 2023

Heathy Participants Trial (Treatment A (BDA MDI HFO), Treatment B (BDA MDI HFA))

Not yet recruiting
  • Heathy Participants
  • Treatment A (BDA MDI HFO)
  • Treatment B (BDA MDI HFA)
  • (no location specified)
Nov 15, 2023

Healthy Volunteers Trial in Baltimore (fezolinetant - test formulation, fezolinetant - reference formulation)

Completed
  • Healthy Volunteers
  • fezolinetant - test formulation
  • fezolinetant - reference formulation
  • Baltimore, Maryland
    PAREXEL Early Phase Clinical Unit
Feb 10, 2022

Healthy Participants Trial in New Haven (Crizotinib)

Completed
  • Healthy Participants
  • New Haven, Connecticut
    New Haven Clinical Research Unit
Jan 18, 2022

Healthy Participants Trial in Groningen, Utrecht (Bosutinib capsule, Bosutinib tablet)

Completed
  • Healthy Participants
  • Bosutinib capsule
  • Bosutinib tablet
  • Groningen, Netherlands
  • +1 more
Feb 14, 2022

Healthy Trial in Edegem (Macitentan)

Recruiting
  • Healthy
  • Edegem, Belgium
    SGS Belgium NV
Aug 16, 2022

Non-Small Cell Lung Carcinoma (NSCLC), Colorectal Cancer (CRC), Other Solid Tumors Trial in Israel (Selinexor 100 mg, Docetaxel,

Recruiting
  • Non-Small Cell Lung Carcinoma (NSCLC)
  • +2 more
  • Selinexor 100 mg
  • +6 more
  • Ashdod, Israel
  • +10 more
Jan 30, 2023

Healthy Subjects Trial in Pilsen (Aprocitentan (Formulation A), Aprocitentan (Formulation B))

Completed
  • Healthy Subjects
  • Aprocitentan (Formulation A)
  • Aprocitentan (Formulation B)
  • Pilsen, Czechia
    CEPHA s.r.o.
Apr 7, 2022

Healthy Volunteers Trial in Hong Kong (SP-01 manufactured by Site K (SP-01-K, Transdermal patch contained granisetron), SP-01

Completed
  • Healthy Volunteers
  • SP-01 manufactured by Site K (SP-01-K, Transdermal patch contained granisetron)
  • SP-01 manufactured by Site A (SP-01-A, Transdermal patch contained granisetron)
  • Hong Kong, Hong Kong
    Phase 1 Clinical Trials Centre, The University of Hong Kong
Feb 7, 2022